Neutrophil lymphocyte ratio as a predictor of severity in patients with COVID-19

Descripción del Articulo

Introduction: The pandemic caused by the coronavirus disease 2019 represented a framework of health, social and economic crisis at a global level, generating great human losses, which is why the need arises to determine the prognostic factors, including some accessible, rapid and low-cost, which may...

Descripción completa

Detalles Bibliográficos
Autores: Vásquez-Sáenz, Nuria Ximena, Valverde-Soriano, Harold Bryce, Alpaca-Salvador, Hugo Aurelio, Vasquez-Saenz, Ruddy Jacqueline
Formato: artículo
Fecha de Publicación:2025
Institución:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Repositorio:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Lenguaje:español
OAI Identifier:oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/2426
Enlace del recurso:https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2426
Nivel de acceso:acceso abierto
Materia:COVID-19
neutrófilos
linfocitos
biomarcadores
neutrophils
lymphocytes
biomarkers
id REVCMH_e1bf17cd6b2c11deae567245dcf25685
oai_identifier_str oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/2426
network_acronym_str REVCMH
network_name_str Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
repository_id_str
dc.title.none.fl_str_mv Neutrophil lymphocyte ratio as a predictor of severity in patients with COVID-19
Ratio neutrófilo linfocito como predictor de gravedad en pacientes con COVID-19
title Neutrophil lymphocyte ratio as a predictor of severity in patients with COVID-19
spellingShingle Neutrophil lymphocyte ratio as a predictor of severity in patients with COVID-19
Vásquez-Sáenz, Nuria Ximena
COVID-19
neutrófilos
linfocitos
biomarcadores
COVID-19
neutrophils
lymphocytes
biomarkers
title_short Neutrophil lymphocyte ratio as a predictor of severity in patients with COVID-19
title_full Neutrophil lymphocyte ratio as a predictor of severity in patients with COVID-19
title_fullStr Neutrophil lymphocyte ratio as a predictor of severity in patients with COVID-19
title_full_unstemmed Neutrophil lymphocyte ratio as a predictor of severity in patients with COVID-19
title_sort Neutrophil lymphocyte ratio as a predictor of severity in patients with COVID-19
dc.creator.none.fl_str_mv Vásquez-Sáenz, Nuria Ximena
Valverde-Soriano, Harold Bryce
Alpaca-Salvador, Hugo Aurelio
Vasquez-Saenz, Ruddy Jacqueline
author Vásquez-Sáenz, Nuria Ximena
author_facet Vásquez-Sáenz, Nuria Ximena
Valverde-Soriano, Harold Bryce
Alpaca-Salvador, Hugo Aurelio
Vasquez-Saenz, Ruddy Jacqueline
author_role author
author2 Valverde-Soriano, Harold Bryce
Alpaca-Salvador, Hugo Aurelio
Vasquez-Saenz, Ruddy Jacqueline
author2_role author
author
author
dc.subject.none.fl_str_mv COVID-19
neutrófilos
linfocitos
biomarcadores
COVID-19
neutrophils
lymphocytes
biomarkers
topic COVID-19
neutrófilos
linfocitos
biomarcadores
COVID-19
neutrophils
lymphocytes
biomarkers
description Introduction: The pandemic caused by the coronavirus disease 2019 represented a framework of health, social and economic crisis at a global level, generating great human losses, which is why the need arises to determine the prognostic factors, including some accessible, rapid and low-cost, which may be useful in predicting potentially serious cases. Objective: Determine if the neutrophil-lymphocyte ratio predicts the severity of COVID-19 according to the severity classification of the Ministry of Health. Materials and methods: A retrospective cohort study was carried out, using consecutive sampling, 200 patients with a confirmed diagnosis of COVID-19 were included upon admission for emergencies at Hospital III EsSalud Chimbote, whose recruitment period was from February to May 2021 with a 30-day follow-up. An multivariate analysis was performed with binary logistic regression in the R Commander version 4.0.5 program, developing a training model to predict the risk of COVID-19 severity during hospitalization. Results: With a stepwise construction strategy from back to front, a model was obtained that included the neutrophil lymphocyte ratio (OR: 1.14) adjusted to lactate dehydrogenase and age as predictors of severe COVID-19; showing an accuracy of 74% for a high-risk threshold greater than  40% and an area under the  curve (AUC) of 0.83 (95%CI:0.78-0.88). Conclusion: The neutrophil-lymphocyte ratio was a independent predictor of the risk of developing severe COVID-19.
publishDate 2025
dc.date.none.fl_str_mv 2025-03-14
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
texto
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2426
10.35434/rcmhnaaa.2024.174.2426
url https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2426
identifier_str_mv 10.35434/rcmhnaaa.2024.174.2426
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2426/1024
dc.rights.none.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo
publisher.none.fl_str_mv Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo
dc.source.none.fl_str_mv Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 No. 4 (2024): Rev. Cuerpo Med. HNAAA, October - December; e2426
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 Núm. 4 (2024): Rev. Cuerpo Med. HNAAA, Octubre - Diciembre; e2426
2227-4731
2225-5109
10.35434/rcmhnaaa.2024.174
reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instacron:HNAAA
instname_str Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instacron_str HNAAA
institution HNAAA
reponame_str Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
collection Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1843898099171328000
spelling Neutrophil lymphocyte ratio as a predictor of severity in patients with COVID-19Ratio neutrófilo linfocito como predictor de gravedad en pacientes con COVID-19Vásquez-Sáenz, Nuria XimenaValverde-Soriano, Harold BryceAlpaca-Salvador, Hugo AurelioVasquez-Saenz, Ruddy JacquelineCOVID-19neutrófiloslinfocitosbiomarcadoresCOVID-19neutrophilslymphocytesbiomarkersIntroduction: The pandemic caused by the coronavirus disease 2019 represented a framework of health, social and economic crisis at a global level, generating great human losses, which is why the need arises to determine the prognostic factors, including some accessible, rapid and low-cost, which may be useful in predicting potentially serious cases. Objective: Determine if the neutrophil-lymphocyte ratio predicts the severity of COVID-19 according to the severity classification of the Ministry of Health. Materials and methods: A retrospective cohort study was carried out, using consecutive sampling, 200 patients with a confirmed diagnosis of COVID-19 were included upon admission for emergencies at Hospital III EsSalud Chimbote, whose recruitment period was from February to May 2021 with a 30-day follow-up. An multivariate analysis was performed with binary logistic regression in the R Commander version 4.0.5 program, developing a training model to predict the risk of COVID-19 severity during hospitalization. Results: With a stepwise construction strategy from back to front, a model was obtained that included the neutrophil lymphocyte ratio (OR: 1.14) adjusted to lactate dehydrogenase and age as predictors of severe COVID-19; showing an accuracy of 74% for a high-risk threshold greater than  40% and an area under the  curve (AUC) of 0.83 (95%CI:0.78-0.88). Conclusion: The neutrophil-lymphocyte ratio was a independent predictor of the risk of developing severe COVID-19.Introducción: La pandemia ocasionada por la enfermedad del coronavirus 2019 representó un marco de crisis sanitaria, social y económica a nivel global, generando grandes pérdidas humanas, por lo que surge la necesidad de determinar los factores pronósticos, entre ellos algunos biomarcadores accesibles, rápidos y de bajo costo, que puedan resultar útiles en predecir los casos potencialmente graves. Objetivo: Determinar si el ratio neutrófilo linfocito predice la gravedad por COVID-19 según la clasificación de severidad del Ministerio de Salud. Materiales y métodos: Se realizó un estudio de cohorte retrospectivo, mediante muestreo consecutivo se incluyó 200 pacientes con diagnóstico confirmado de COVID-19 al ingreso por emergencias del Hospital III EsSalud Chimbote, cuyo periodo de reclutamiento fue de febrero a mayo del año 2021 con un seguimiento de 30 días. Se realizó un análisis multivariante con regresión logística binaria en el programa R Commander versión 4.0.5 desarrollando un modelo de entrenamiento para predecir el riesgo de gravedad del COVID-19 durante la hospitalización. Resultados: Con una estrategia de construcción stepwise de atrás hacia adelante se obtuvo un modelo predictivo que incluyó el ratio neutrófilo linfocito (OR:1,14) ajustado a la lactato deshidrogenasa y la edad como predictores del COVID-19 grave; mostrando una exactitud del 74% para un umbral de alto riesgo mayor a 40% y un área bajo la curva (AUC) de 0,83 (IC95%:0,78-0,88). Conclusión: El ratio neutrófilo linfocito fue un predictor independiente del riesgo de desarrollar COVID-19 grave.Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo2025-03-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontextoapplication/pdfhttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/242610.35434/rcmhnaaa.2024.174.2426Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 No. 4 (2024): Rev. Cuerpo Med. HNAAA, October - December; e2426Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 Núm. 4 (2024): Rev. Cuerpo Med. HNAAA, Octubre - Diciembre; e24262227-47312225-510910.35434/rcmhnaaa.2024.174reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstacron:HNAAAspahttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2426/1024Derechos de autor 2025 Nuria Ximena Vásquez Sáenz, Hugo Aurelio Alpaca Salvador, Ruddy Jacqueline Vasquez Saenz, Harold Bryce Valverde Sorianohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/24262025-05-19T04:52:26Z
score 13.360325
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).